bibliographic entry 12414290 [be/12414290]
https://w3id.org/oc/corpus/be/12414290

is a

• bibliographic reference

content

• Angevin, E, Lin, C, Pande, A. U, & Lopez, J. A. (2010). A phase I/II study of dovitinib (TKI258), a FGFR and VEGFR inhibitor, in patients (pts) with advanced or metastatic renal cell cancer: phase I results. ASCO Meeting \ldots.

references

• https://w3id.org/oc/corpus/br/8212790